Other captive investment companies
CULEX AS
Revenue 2025
NOK 0
Operating profit
NOK −104,000
Equity
NOK 6.4m
Incorporated
2005
Share capital
NOK 136,000
Roles
Regnskapsfører
Styrets lederPaul Tore Nielsen
StyremedlemChristine Øygarden Zountourides
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| PAUL TORE NIELSEN | 100.0% | 136.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| PHARMASUM THERAPEUTICS AS | Active | 0.0% | 788.000000 |
| LYTIX BIOPHARMA ASA | Active | 0.0% | 14750.000000 |
| AMICOAT AS | Active | 0.0% | 8368.000000 |
| PHARMA HOLDINGS AS | Active | 0.0% | 167.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.